Page results
-
Your treatment for acute lymphoblastic leukaemia (ALL) will be delivered within a number of comprehensive specialised services led by medical and nursing cancer care experts.
-
Acute lymphoblastic leukaemia (ALL) is a form of cancer that affects the cells in the bone marrow, the soft material inside your bones.
-
A large trial at UCLH and UCL will investigate whether a drug currently in use to treat respiratory conditions can slow the progress of Parkinson’s disease.
-
Your acute myeloid leukaemia (AML) treatment will be delivered within a number of comprehensive specialised services led by medical and nursing cancer care experts.
-
Exhibition co-curated by Healthcare Arts Collective and UCLH Arts and Heritage 25th August - 20th October 2021, UCH Street Gallery, 235 Euston Road
-
Acute Myeloid Leukaemia (AML) is a form of cancer that develops in your bone marrow and affects your blood cells.
-
Breakthroughs in Alzheimer’s disease are exciting and invigorating dementia research, and we will need to be ready to deliver new treatments as they come through, say Professor Nick Fox and Dr Catherine Mummery.
-
Medtronic are running a series of patient webinars for anyone with Type 1 Diabetes using the MiniMed™ 780G pump or system.
-
New precision therapy for bile duct cancer extends patients’ lives
-
Information about endovascular treatments of AVMs undertaken in the NHNN angiography suite.
File results
-
FOI/2024/0277 - Paediatric respiratory admission rates 2018-2023
-
FOI/2024/0337 - IVF clinical unit/ embryology laboratory
-
FOI/2024/0326 - Treatment of Haemophilia B and Von Willebrand disease
-
FOI/2024/0327 - Treatment of non-UK nationals
-
FOI/2024/0329 - Metastatic renal cell carcinoma patients/ classification
-
FOI/2024/0464 - Theatre sessions/ productivity
-
FOI/2024/0467 - Drug Patient Level Contract Monitoring (DrPLCM) and SACT Cancer reports
-
FOI/2024/0333 - Elective treatment wait over 65 weeks
-
FOI/2024/0347 - Paediatric elective surgical waiting lists
-
FOI/2024/0344 - Cancer diagnosis following A&E attendance 2018-2023